Publications
- Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy2018 | First Faculty of Medicine
- The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients2018 | Faculty of Medicine in Hradec Králové
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Science
- Impact of age on the clinical response of patients with CML treated with imatinib2015 | Faculty of Medicine in Hradec Králové
- No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia2014 | Publication without faculty affiliation
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- Commentary to the study +12009 | Faculty of Medicine in Hradec Králové
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AV001Publication without faculty affiliation
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib2024 | First Faculty of Medicine
Loading network view...
